Today

Agents

Chat

Arena

Discover

More

App

Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing - KROS News | Rallies

Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing

KROS•2026-09-10

SEC filing outlines potential securities offering

Sept. 10 (Reuters) - Keros Therapeutics, Inc. KROS.O:

Keros Therapeutics may offer up to $350 million of securities, according to an SEC filing.
The company may offer up to $100 million of common stock under a sales agreement with Leerink Partners, the filing said.

Related News

CVD Equipment names Warren Cheesman acting CEO as Emmanuel Lakios steps down

CVV•2026-09-10

TransCode Therapeutics Appoints John Tattory As Interim CFO

RNAZ•2026-09-10

Vernal Capital Acquisition swings to FY26 Q2 net income of USD 612,215

•

2026-09-10

Conduent agrees in principle to settle New Jersey data breach lawsuit after January 2025 cyber incident

CNDT•2026-09-10

Kadant names Michael Colwell CEO effective Jan. 2, 2027

KAI•2026-09-10